Fortrea Holdings Inc. (FTRE)
NASDAQ:FTRE
Want to see FTRE full AI Analyst Report?
FTRE Stock Chart & Stats
$10.38
-$0.82(-4.27%)
At close: 4:00 PM EST
$10.38
-$0.82(-4.27%)
Day’s Range― - ―
52-Week Range$4.36 - $18.67
Previous CloseN/A
Volume188.47K
Average Volume (3M)1.80M
Market Cap
$1.45B
Enterprise Value$2.42B
Total Cash (Recent Filing)$147.50M
Total Debt (Recent Filing)$1.12B
Price to Earnings (P/E)―
Beta1.98
Next Earnings
Aug 17, 2026EPS Estimate
0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.93
Shares Outstanding94,600,000
10 Day Avg. Volume2,205,510
30 Day Avg. Volume1,801,545
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)2.79
Price to Sales (P/S)0.58
P/FCF Ratio17.82
Enterprise Value/Market Cap1.67
Enterprise Value/Revenue0.89
Enterprise Value/Gross Profit5.59
Enterprise Value/Ebitda-8.61
Forecast
1Y Price Target
$15.44Price Target Upside48.72% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)0.8
Revenue Forecast (FY)$2.61B
Bulls Say, Bears Say
Bulls Say
Cash Generation And LiquiditySustained positive TTM operating and free cash flow and >$0.5B liquidity indicate the company can fund operations, invest in growth and service debt without relying on equity markets. This durability supports multi‑quarter stability while earnings recover and cost programs materialize.
Improving Commercial Momentum And BacklogA book-to-bill consistently above 1 and a large backlog signal durable demand and visibility into future revenue. This supports revenue stability over the coming quarters and underpins the firm's ability to convert pipeline into billings as operational execution improves.
Technology Differentiation (FIT Launch)Introducing an AI-enabled platform creates a structural advantage in efficiency, trial execution and win rates over time. If adopted, FIT can improve project margins, shorten timelines and strengthen client stickiness, supporting sustained competitive differentiation.
Bears Say
Sharp Revenue Decline And Margin CompressionA steep TTM revenue drop and materially lower gross margins indicate weakened underlying demand/price realization and worse mix. That reduces earnings resilience and makes multi‑quarter margin recovery dependent on sustained demand, pricing restoration and successful cost actions.
Customer ConcentrationHigh revenue concentration elevates idiosyncratic risk: loss or renegotiation by a major client can materially impact revenue and utilization. Over the medium term this constrains predictability and bargaining power unless the customer mix diversifies.
Persistent Losses And Weak ROEDeep negative ROE and continued net losses signal that equity value creation is impaired. Even with cash generation improvements, sustained earnings recovery is required to normalize returns; prolonged losses could limit reinvestment and strategic flexibility.
Fortrea Holdings Inc. News
FTRE FAQ
What was Fortrea Holdings Inc.’s price range in the past 12 months?
Fortrea Holdings Inc. lowest stock price was $4.36 and its highest was $18.67 in the past 12 months.
What is Fortrea Holdings Inc.’s market cap?
Fortrea Holdings Inc.’s market cap is $1.45B.
When is Fortrea Holdings Inc.’s upcoming earnings report date?
Fortrea Holdings Inc.’s upcoming earnings report date is Aug 17, 2026 which is in 56 days.
How were Fortrea Holdings Inc.’s earnings last quarter?
Fortrea Holdings Inc. released its earnings results on May 05, 2026. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.061 by $0.099.
Is Fortrea Holdings Inc. overvalued?
According to Wall Street analysts Fortrea Holdings Inc.’s price is currently Undervalued.
Does Fortrea Holdings Inc. pay dividends?
Fortrea Holdings Inc. does not currently pay dividends.
What is Fortrea Holdings Inc.’s EPS estimate?
Fortrea Holdings Inc.’s EPS estimate is 0.18.
How many shares outstanding does Fortrea Holdings Inc. have?
Fortrea Holdings Inc. has 94,600,000 shares outstanding.
What happened to Fortrea Holdings Inc.’s price movement after its last earnings report?
Fortrea Holdings Inc. reported an EPS of $0.16 in its last earnings report, beating expectations of $0.061. Following the earnings report the stock price went up 18.612%.
Which hedge fund is a major shareholder of Fortrea Holdings Inc.?
Currently, no hedge funds are holding shares in FTRE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Fortrea Holdings Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.44 (48.72% Upside)
$15.44 (48.72% Upside)
Hedge Fund Trend
Increased
By 357.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $105.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.29%
12-Months-Change
Fundamentals
Return on Equity
-79.12%
Trailing 12-Months
Asset Growth
-14.02%
Trailing 12-Months
Company Description
Fortrea Holdings Inc.
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.
FTRE Company Deck
FTRE Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call balanced clear operational and commercial progress (book-to-bill >1.1x, adjusted EBITDA growth, large backlog, strong cost savings, FIT launch, China momentum and improved cash flow metrics) against near-term revenue pressure driven by lower pass-throughs and FSP pricing concessions, customer concentration and continued negative (though improved) Q1 cash flow. Management reiterated full-year guidance and a multi-year plan to reach mid-teens adjusted EBITDA margins. Overall, the positive operational, financial and commercial momentum and materially improved profitability and cash metrics outweigh the listed headwinds.View all FTRE earnings summariesFTRE Stock 12 Month Forecast
Average Price Target
$15.44
▲(48.72% Upside)
Technical Analysis
Nektar Therapeutics
―
Fulcrum Therapeutics
―
Compass Therapeutics
―
Erasca
―
Aura Biosciences Inc
―
Ownership Overview
0.72% Insiders
20.85% Mutual Funds
27.10% Other Institutional Investors
15.88% Public Companies and
Individual Investors